pSivida’s Iluvien close to UK reimbursement
17 June, 2013 by Dylan Bushell-EmblingThe UK’s NICE has issued a draft decision recommending reimbursement of Iluvien, an ocular insert developed by pSivida (ASX:PVA), for pseudophakic DME patients.
QRxPharma wins US patent for opioid compounds
13 June, 2013QRxPharma (ASX:QRX) has been granted a US patent covering linking morphine and oxycodone molecules to form a more potent hybrid compound.
Updates on agricultural biotechnology made easy
13 June, 2013The Agricultural Biotechnology Council of Australia (ABCA) invites you to join its email list to receive regular updates on current and emerging issues in agricultural biotechnology in Australia.
UBI wins Vic government manufacturing award
12 June, 2013 by Dylan Bushell-EmblingUniversal Biosensors (ASX:UBI) has picked up a Victorian government manufacturing award recognising innovative use of technology in its production processes.
Australian doctors back asthma system, says iSonea
12 June, 2013 by Dylan Bushell-EmblingiSonea (ASX:ISN) has released the results of a survey suggesting that 80% of Australian GPs and 62% of paediatricians would recommend its upcoming mobile wheeze-monitoring system.
Applications invited for export awards
11 June, 2013The Australian Export Awards has commenced its 2013 campaign to crown Australia’s exporting success stories.
New site for bioscience businesses
11 June, 2013A new purpose-built technology hub to support emerging high-tech businesses has been established in South Australia.
ResMed files patent suit against Chinese vendor
07 June, 2013 by Dylan Bushell-EmblingResMed (ASX:RMD) has filed a US patent violation lawsuit against Chinese manufacturer BMC and is seeking to have the company added to its pending ITC case.
IP Laws Bill progressed after Productivity Commission Report
06 June, 2013The federal government has moved to amend intellectual property Crown use provisions following recommendations in the Productivity Commission Inquiry Report on the compulsory licensing of patents.
Consegna trials BreatheAssist in athletes
06 June, 2013 by Dylan Bushell-EmblingConsegna (ASX:CGP) said two thirds of athletes trialling the prototype of the sport version of its BreatheAssist device felt they were able to take more air into their lungs.
Bioniche signs licensing, funding deal with Paladin
06 June, 2013 by Dylan Bushell-EmblingBioniche (ASX:BNC) has entered a debt refinancing, funding and Urocidin licensing agreement with Canada’s Paladin Labs.
Mesoblast wins Japanese patent for stem cell platform
05 June, 2013 by Dylan Bushell-EmblingMesoblast (ASX:MSB) has secured a Japanese patent offering broad protection for its MPC adult stem cell platform in the market through to 2025.
FB Rice names Melbourne biotech partners
05 June, 2013 by Dylan Bushell-EmblingAustralian intellectual property advisory firm FB Rice has appointed two new partners for its Melbourne biotechnology and chemistry practice.
ResMed launches online sleep breathing tool
04 June, 2013 by Dylan Bushell-EmblingResMed (ASX:RMD) has launched a new online - and soon mobile - app to help sleep-disordered breathing patients track their therapy progress and set goals.
Immuron to sell Travelan straight to wholesalers
04 June, 2013 by Dylan Bushell-EmblingImmuron (ASX:IMC) has dissolved its relationship with ANZ distributor Takeda and will start selling its flagship Travelan product directly to wholesalers in the markets.
